Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be used ...

Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial. The findings challenge ...

It wasn’t every day that Patricia Torres raced down the streets of Miami at 70 m.p.h. But then it wasn’t every day that her daughter Nicole Cabezas hallucinated wildly, trying to jump out of the car, ...

While they share similar depressive and cognitive symptoms, the biological underpinnings of bipolar disorder and major ...

Bipolar episodes can occur at random, but they’re often associated with specific circumstances. By identifying these thoughts, feelings, and events, you can learn to better manage situations that are ...

Synthetic psilocybin with psychotherapy was effective and safe for patients with treatment-resistant bipolar depression, a small nonrandomized controlled trial suggested. Among 15 people with bipolar ...

One dose of synthetic psilocybin in combination with psychotherapy significantly reduces treatment-resistant depression associated with bipolar II disorder (BDII), a small, nonrandomized clinical ...

The approval of medicines called second-generation antipsychotics has allowed bipolar I and other associated conditions to be treated. A person with bipolar I disorder can go through various mood ...

Bipolar disorder causes significant and sustained fluctuations in mood. This differs from the fleeting mood swings that many people experience from time to time. Mood swings are very common and may ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Depression and bipolar disorder may have seasonal patterns in more ...